Although, embelin has been reported to inhibit IL6/STAT3 and NF-κB signaling pathways [6,9,10,11,31], whether embelin can utilize these properties to prevent the progression of atherosclerosis also needs to be further clarified. Here, STAT3 is linked to atherosclerosis.